Stocks · Health care · Pharmaceutical Preparations

Lipocine Inc.

LPCN Clue Score54
United States Fiscal year ends December CIK 0001535955
$1.72 -10.88% Close, 9 Oct 2026
Price $1.72 +60.75% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue0.0Operating income−19.2Net income−19.0EPS, diluted−1.04Fiscal year 2017Revenue0.0Operating income−21.2Net income−21.0EPS, diluted−1.05Fiscal year 2018Revenue0.4Operating income−11.3Net income−11.7EPS, diluted−0.55Fiscal year 2019Revenue0.2 −61.5%Operating income−12.9Net income−13.0EPS, diluted−0.50Fiscal year 2020Revenue0.0 −100.0%Operating income−18.0Net income−21.0EPS, diluted−0.38Fiscal year 2021Revenue16.1Operating income3.1Net income−0.6EPS, diluted−0.01Fiscal year 2022Revenue0.5 −96.9%Operating income−12.1Net income−10.8EPS, diluted−2.15Fiscal year 2023Revenue−2.9 −670.2%Operating income−17.9Net income−16.4EPS, diluted−3.14Fiscal year 2024Revenue11.2Operating income−1.2Net income0.0Fiscal year 2025Revenue2.0 −82.3%Operating income−10.4Net income−9.6 −115,371.9%EPS, diluted−1.69
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 0.0 0.0 0.4 0.2 0.0 16.1 0.5 −2.9 11.2 2.0
Growth −61.5% −100.0% −96.9% −670.2% −82.3%
Operating income −19.2 −21.2 −11.3 −12.9 −18.0 3.1 −12.1 −17.9 −1.2 −10.4
Net income −19.0 −21.0 −11.7 −13.0 −21.0 −0.6 −10.8 −16.4 0.0 −9.6
Growth −115,371.9%
EPS, diluted −1.04 −1.05 −0.55 −0.50 −0.38 −0.01 −2.15 −3.14 n/a −1.69

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2016Fiscal year 2017Fiscal year 2018Operating margin−2,646.0%Net margin−2,724.1%Free cash flow margin−2,822.0%Fiscal year 2019Operating margin−7,818.8%Net margin−7,883.7%Fiscal year 2020Fiscal year 2021Operating margin19.5%Net margin−3.9%Free cash flow margin−27.4%Fiscal year 2022Operating margin−2,423.9%Net margin−2,151.7%Free cash flow margin−2,420.5%Fiscal year 2023Operating margin629.0%Net margin573.6%Free cash flow margin416.7%Fiscal year 2024Operating margin−10.3%Net margin0.1%Free cash flow margin−11.7%Fiscal year 2025Operating margin−524.7%Net margin−487.1%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating margin n/a n/a −2,646.0% −7,818.8% n/a 19.5% −2,423.9% 629.0% −10.3% −524.7%
Net margin n/a n/a −2,724.1% −7,883.7% n/a −3.9% −2,151.7% 573.6% 0.1% −487.1%
Free cash flow margin n/a n/a −2,822.0% n/a n/a −27.4% −2,420.5% 416.7% −11.7% n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−18.3Capital expenditure−0.1Free cash flow−18.3Fiscal year 2017Operating cash flow−16.7Capital expenditure0.0Free cash flow−16.7Fiscal year 2018Operating cash flow−12.1Capital expenditure0.0Free cash flow−12.1Fiscal year 2019Operating cash flow−11.7Fiscal year 2020Operating cash flow−15.3Fiscal year 2021Operating cash flow−4.4Capital expenditure−0.0Free cash flow−4.4Fiscal year 2022Operating cash flow−12.0Capital expenditure−0.1Free cash flow−12.1Fiscal year 2023Operating cash flow−11.9Capital expenditure−0.0Free cash flow−11.9Fiscal year 2024Operating cash flow−1.2Capital expenditure−0.1Free cash flow−1.3Fiscal year 2025Operating cash flow−9.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −18.3 −16.7 −12.1 −11.7 −15.3 −4.4 −12.0 −11.9 −1.2 −9.8
Capital expenditure −0.1 0.0 0.0 n/a n/a −0.0 −0.1 −0.0 −0.1 n/a
Free cash flow −18.3 −16.7 −12.1 n/a n/a −4.4 −12.1 −11.9 −1.3 n/a
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash5.6Shareholders’ equity26.0Fiscal year 2017Cash3.2Total debt0.0Net cash (debt)3.2Shareholders’ equity19.0Debt to equity0.00Fiscal year 2018Cash8.1Total debt6.9Net cash (debt)1.2Shareholders’ equity9.4Debt to equity0.73Fiscal year 2019Cash9.7Total debt3.8Net cash (debt)5.9Shareholders’ equity6.3Debt to equity0.61Fiscal year 2020Cash19.2Total debt2.3Net cash (debt)17.0Shareholders’ equity15.3Debt to equity0.15Fiscal year 2021Cash3.0Total debt1.7Net cash (debt)1.3Shareholders’ equity45.6Debt to equity0.04Fiscal year 2022Cash3.1Shareholders’ equity35.6Fiscal year 2023Cash4.8Shareholders’ equity20.4Fiscal year 2024Cash6.2Shareholders’ equity21.0Fiscal year 2025Cash5.2Shareholders’ equity14.5
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 5.6 3.2 8.1 9.7 19.2 3.0 3.1 4.8 6.2 5.2
Total debt n/a 0.0 6.9 3.8 2.3 1.7 n/a n/a n/a n/a
Net cash (debt) n/a 3.2 1.2 5.9 17.0 1.3 n/a n/a n/a n/a
Shareholders’ equity 26.0 19.0 9.4 6.3 15.3 45.6 35.6 20.4 21.0 14.5
Debt to equity n/a 0.00 0.73 0.61 0.15 0.04 n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Balance sheet

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020† 31 Dec 2020 FY2021† 31 Dec 2021 FY2022† 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Assets
5.6 3.2 8.1 9.7 19.2 3.0 3.1 4.8 6.2 5.2
0.1 0.1 0.0 0.0 n/a 0.0 0.1 0.1 0.2 0.1
27.3 25.3 20.9 19.7 25.4 52.5 37.5 23.0 22.5 17.0
Growth −7.4% −17.7% −5.7% +29.0% +107.0% −28.5% −38.7% −2.1% −24.5%
Liabilities
n/a 0.0 6.9 3.8 2.3 1.7 n/a n/a n/a n/a
calc n/a 0.0 6.9 3.8 2.3 1.7 n/a n/a n/a n/a
1.3 6.3 11.4 13.4 10.0 6.9 1.9 2.6 1.5 2.5
Equity
−105.4 −126.4 −138.1 −151.1 −172.0 −172.7 −183.4 −199.8 −199.8 −209.4
26.0 19.0 9.4 6.3 15.3 45.6 35.6 20.4 21.0 14.5
Growth −27.0% −50.3% −33.3% +144.0% +197.0% −21.8% −42.8% +3.1% −31.1%
Per share and net cash
calc n/a 3.2 1.2 5.9 17.0 1.3 n/a n/a n/a n/a
18.5 21.3 21.7 37.6 70.0 88.3 5.2 5.3 5.3 6.2
calc 1.41 0.89 0.43 0.17 0.22 0.52 6.81 3.83 3.93 2.35

† The diluted share count jumps at 2020 and 2021 and 2022, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how.